Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies Read more
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio Read more
AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine Read more
Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions Read more
Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer Read more
FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients Read more